Armata Pharmaceuticals, Inc. (ARMP)
NYSE: ARMP · Biological Products, (No Diagnostic Substances) · Los Angeles, CA · filing with the SEC since 1996
Who owns Armata Pharmaceuticals, Inc.
As filed with the SECHolders of 5% or more
1
Innoviva, Inc. holds 82.7% of Common Stock, $0.01 par value, as its SCHEDULE 13D/A filed May 13, 2026 says.
Directors and officers
10
report now, of 30 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Innoviva, Inc.
SCHEDULE 13D/A · filed May 13, 2026 · Common Stock, $0.01 par value · 83.1% in Jan 26, 2026
What ARMP reports owning in othersstakes of 5% or more, and other ties
5 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 21, 2025.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2022 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.